Indaptus Therapeutics, Inc. (INDP) Tops Q1 EPS by 8c

Indaptus Therapeutics, Inc. (NASDAQ: INDP) reported Q1 EPS of ($0.51), $0.08 better than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Indaptus Therapeutics, Inc. (INDP) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Ross Stores, Inc. (ROST) PT Raised to $240 at Bernstein SocGen Group
• ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04